Search Results

There are 4127 results for: content related to: Outcome of induction immunosuppression for liver transplantation comparing anti-thymocyte globulin, daclizumab, and corticosteroid

  1. Long-term follow-up of children treated with daclizumab for steroid-refractory gastrointestinal GvHD in a prospective study

    Pediatric Transplantation

    Volume 16, Issue 6, September 2012, Pages: 664–669, Amir Ali Hamidieh, Molouk Hadjibabaie, Maryam Taghizadeh Ghehi, Mahdi Jalili, Ashrafsadat Hosseini, Farahnaz Pasha, Maryam Behfar and Ardeshir Ghavamzadeh

    Version of Record online : 28 JUN 2012, DOI: 10.1111/j.1399-3046.2012.01753.x

  2. You have free access to this content
    Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis

    Transplant International

    Volume 13, Issue 2, March 2000, Pages: 151–159, Henrik Ekberg, Lars Bäckman, Gunnar Tufveson, Gunnar Tydén, Björn Nashan and Flavio Vincenti

    Version of Record online : 2 JUN 2008, DOI: 10.1111/j.1432-2277.2000.tb01056.x

  3. You have free access to this content
    Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation

    Transplant International

    Volume 22, Issue 2, February 2009, Pages: 182–191, Christian Toso, Ryan Edgar, Rena Pawlick, Juliet Emamaullee, Shaheed Merani, Parastoo Dinyari, Thomas F. Mueller, A. M. James Shapiro and Colin C. Anderson

    Version of Record online : 15 AUG 2008, DOI: 10.1111/j.1432-2277.2008.00746.x

  4. Population PK–PD analyses of CD25 occupancy, CD56bright NK cell expansion, and regulatory T cell reduction by daclizumab HYP in subjects with multiple sclerosis

    British Journal of Clinical Pharmacology

    Volume 82, Issue 5, November 2016, Pages: 1333–1342, Lei Diao, Yaming Hang, Ahmed A. Othman, Devangi Mehta, Lakshmi Amaravadi, Ivan Nestorov and Jonathan Q. Tran

    Version of Record online : 3 AUG 2016, DOI: 10.1111/bcp.13051

  5. Extended daclizumab monotherapy for rejection-free survival in non-adherent adolescent recipients of renal allografts

    Pediatric Transplantation

    Volume 13, Issue 7, November 2009, Pages: 927–932, Abanti Chaudhuri, Oscar Salvatierra, Jr. and Minnie M. Sarwal

    Version of Record online : 9 NOV 2008, DOI: 10.1111/j.1399-3046.2008.01081.x

  6. You have free access to this content
    Daclizumab induction therapy in liver transplant recipients with renal insufficiency

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 6, September 2010, Pages: 776–786, S. K. Asrani, W. R. Kim, R. A. Pedersen, M. R. Charlton, W. K. Kremers, T. M. Therneau, C. B. Rosen and P. G. Dean

    Version of Record online : 26 JUL 2010, DOI: 10.1111/j.1365-2036.2010.04408.x

  7. You have free access to this content
    TRANSPLANT 2001: The Joint American Transplant Meeting

    American Journal of Transplantation

    Volume 1, Issue S1, May 2001, Pages: 47–476,

    Version of Record online : 25 AUG 2010, DOI: 10.1111/j.1600-6143.2001.tb00014.x

  8. You have free access to this content
    Disengaging the IL-2 Receptor with Daclizumab Enhances IL-7–Mediated Proliferation of CD4+ and CD8+ T Cells

    American Journal of Transplantation

    Volume 9, Issue 12, December 2009, Pages: 2727–2735, P. Monti, C. Brigatti, A. K. Heninger, M. Scirpoli and E. Bonifacio

    Version of Record online : 25 SEP 2009, DOI: 10.1111/j.1600-6143.2009.02825.x

  9. You have free access to this content
    Effect of Anti-IL-2Rα Antibody on IL-2-induced Jak/STAT Signaling

    American Journal of Transplantation

    Volume 2, Issue 1, January 2002, Pages: 31–40, Jean Tkaczuk, Chao-Lan Yu, Shairaz Baksh, Edgar L. Milford, Charles B. Carpenter, Steven J. Burakoff and Dianne B. McKay

    Version of Record online : 20 MAR 2002, DOI: 10.1034/j.1600-6143.2002.020107.x

  10. You have free access to this content
    Daclizumab for relapsing remitting multiple sclerosis

    Intervention Review

    The Cochrane Library

    Jia Liu, Lu-Ning Wang, Siyan Zhan and Yinyin Xia

    Published Online : 23 DEC 2013, DOI: 10.1002/14651858.CD008127.pub4

  11. You have free access to this content
    Prophylactic and therapeutic effects of a humanized monoclonal antibody against the IL-2 receptor (DACLIZUMAB) on collagen-induced arthritis (CIA) in rhesus monkeys

    Clinical & Experimental Immunology

    Volume 124, Issue 1, April 2001, Pages: 134–141, H. P. M. Brok, J. M. Tekoppele, J. Hakimi, J. A. Kerwin, E. M. Nijenhuis, C. W. De Groot, R. E. Bontrop and B. A. ‘t Hart

    Version of Record online : 12 JAN 2002, DOI: 10.1046/j.1365-2249.2001.01487.x

  12. You have full text access to this OnlineOpen article
    Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis

    Annals of Clinical and Translational Neurology

    Volume 2, Issue 5, May 2015, Pages: 445–455, Yen Chih Lin, Paige Winokur, Andrew Blake, Tianxia Wu, Elena Romm and Bibiana Bielekova

    Version of Record online : 7 APR 2015, DOI: 10.1002/acn3.181

  13. Safety and pharmacokinetics of daclizumab in pediatric renal transplant recipients

    Pediatric Transplantation

    Volume 12, Issue 4, June 2008, Pages: 447–455, Mark D. Pescovitz, Stuart Knechtle, Steven R. Alexander, Paul Colombani, Tom Nevins, Keith Nieforth and M. René Bouw

    Version of Record online : 24 OCT 2007, DOI: 10.1111/j.1399-3046.2007.00830.x

  14. Interleukin 2 receptor antagonists for kidney transplant recipients

    Intervention Review

    The Cochrane Library

    Angela C Webster, Lorenn P Ruster, Richard G McGee, Sandra L Matheson, Gail Y Higgins, Narelle S Willis, Jeremy R Chapman and Jonathan C Craig

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD003897.pub3

  15. You have free access to this content
    American Transplant Congress 2007 Executive and Program Planning Committees and Abstract Review Committees

    American Journal of Transplantation

    Volume 7, Issue s2, May 2007, Pages: 17–584,

    Version of Record online : 26 APR 2007, DOI: 10.1111/j.1600-6143.2007.01811.x

  16. You have free access to this content
    A novel three-dose regimen of daclizumab in liver transplant recipients with hepatitis C: A pharmacokinetic and pharmacodynamic study

    Liver Transplantation

    Volume 12, Issue 4, April 2006, Pages: 585–591, W. Kenneth Washburn, Lewis W. Teperman, Thomas G. Heffron, David D. Douglas, Steven Gay, Eliezer Katz and Goran B.G. Klintmalm

    Version of Record online : 2 FEB 2006, DOI: 10.1002/lt.20631

  17. You have free access to this content
    Monoclonal antibodies in treatment of multiple sclerosis

    Clinical & Experimental Immunology

    Volume 175, Issue 3, March 2014, Pages: 373–384, P. S. Rommer, A. Dudesek, O. Stüve and U.K. Zettl

    Version of Record online : 4 FEB 2014, DOI: 10.1111/cei.12197

  18. Pharmacokinetics of daclizumab and mycophenolate mofetil with cyclosporine and steroids in renal transplantation

    Clinical Transplantation

    Volume 17, Issue 6, December 2003, Pages: 511–517, Mark D Pescovitz, Ginny Bumgardner, Robert S Gaston, Robert L Kirkman, Susan Light, Indravadan H Patel, Keith Nieforth and Flavio Vincenti

    Version of Record online : 4 NOV 2003, DOI: 10.1046/j.1399-0012.2003.00079.x

  19. You have free access to this content
    Antibody induction versus corticosteroid induction for liver transplant recipients

    Intervention Review

    The Cochrane Library

    Luit Penninga, André Wettergren, Colin H Wilson, An-Wen Chan, Daniel A Steinbrüchel and Christian Gluud

    Published Online : 31 MAY 2014, DOI: 10.1002/14651858.CD010252.pub2

  20. Direct inhibition of interleukin-2 receptor α-mediated signaling pathway induces G1 arrest and apoptosis in human head-and-neck cancer cells

    Journal of Cellular Biochemistry

    Volume 95, Issue 2, 15 May 2005, Pages: 379–390, Deborah J. Kuhn and Q. Ping Dou

    Version of Record online : 18 MAR 2005, DOI: 10.1002/jcb.20446